REGULUS THERAPEUTICS INC

NASDAQ: RGLS (Regulus Therapeutics Inc.)

Last update: 11 hours ago

7.87

0.02 (0.25%)

  • 1D 0.25%
  • 5D 0.00%
  • 1M 291.54%
  • 6M 454.23%
  • YTD 404.49%
  • 1Y 291.54%
  • 5Y 26.94%
Previous Close 7.85
Open 7.85
Volume 860,014
Avg. Volume (3M) 1,924,560
Market Cap 544,872,320
Price / Book 2.39
52 Weeks Range
0.830 (-89%) — 8.20 (4%)
Earnings Date 6 Aug 2025 - 11 Aug 2025
Diluted EPS (TTM) -0.820
Total Debt/Equity (MRQ) 1.38%
Current Ratio (MRQ) 10.98
Operating Cash Flow (TTM) -41.67 M
Levered Free Cash Flow (TTM) -25.53 M
Return on Assets (TTM) -54.42%
Return on Equity (TTM) -95.00%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Regulus Therapeutics Inc. Bearish Bearish

AIStockmoo Score

0.1
Analyst Consensus -0.5
Insider Activity NA
Price Volatility -3.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average 0.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
RGLS 545 M - - 2.39
VIR 603 M - - 0.660
REPL 560 M - - 1.12
ZVRA 474 M - - 9.93
SANA 394 M - - 1.48
ORIC 336 M - - 1.53

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 2.18%
% Held by Institutions 86.69%

Ownership

Name Date Shares Held
Federated Hermes, Inc. 31 Mar 2025 15,819,863
Octagon Capital Advisors Lp 31 Mar 2025 4,637,076
Deep Track Capital, Lp 31 Mar 2025 3,262,564
Baker Bros. Advisors Lp 31 Mar 2025 2,694,044
Point72 Asset Management, L.P. 31 Mar 2025 1,968,293
Driehaus Capital Management Llc 31 Mar 2025 958,345
Alyeska Investment Group, L.P. 31 Mar 2025 937,500
Dafna Capital Management Llc 31 Mar 2025 847,176
Sphera Funds Management Ltd. 31 Mar 2025 452,845
52 Weeks Range
0.830 (-89%) — 8.20 (4%)
Price Target Range
7.00 (-11%) — 11.00 (39%)
High 11.00 (Canaccord Genuity, 39.77%) Hold
Median 9.00 (14.36%)
Low 7.00 (Jones Trading, -11.06%) Hold
7.00 (Leerink Partners, -11.06%) Hold
Average 8.80 (11.82%)
Total 1 Buy, 4 Hold
Avg. Price @ Call 6.65
Firm Date Target Price Call Price @ Call
Wells Fargo 01 May 2025 9.00 (14.36%) Hold 7.85
27 Mar 2025 6.00 (-23.76%) Buy 1.50
Canaccord Genuity 30 Apr 2025 11.00 (39.77%) Hold 7.98
17 Mar 2025 28.00 (255.78%) Buy 1.37
Jones Trading 30 Apr 2025 7.00 (-11.05%) Hold 7.98
Leerink Partners 30 Apr 2025 7.00 (-11.05%) Hold 7.98
HC Wainwright & Co. 14 Mar 2025 10.00 (27.06%) Buy 1.48
26 Feb 2025 10.00 (27.06%) Buy 1.36

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria